全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
药学学报  2013 

粒径与表面电荷影响脂质体体内药物靶向递送的研究进展

, PP. 1644-1650

Keywords: 脂质体,粒径,表面电荷,药物递送,体内靶向

Full-Text   Cite this paper   Add to My Lib

Abstract:

脂质体进入体内血液循环,通过被动靶向作用聚集于网状内皮系统(reticuloendothelialsystem,res)比较丰富的器官。靶向性是脂质体作为药物载体的一个重要特征,粒径和表面电荷是影响脂质体在体内被动靶向的重要理化因素。本文阐述了脂质体的粒径和表面电荷对其与细胞结合和被细胞摄取的影响,并从体内组织器官的生理特点出发,介绍了粒径和表面电荷对脂质体在血液、肝、脾及肿瘤组织分布的影响。对今后的研究方向进行了展望。

References

[1]  chengj.developmentoftargetingthermosensitiveliposomesfortumortreatment[j].actapharmsin(药学学报),2011,46:502-506.
[2]  hecb,huyp,yinlc,etal.effectsofparticlesizeandsurfacechargeoncellularuptakeandbiodistributionofpolymericnanoparticles[j].biomaterials,2010,31:3657-3666.
[3]  rieuxad,fievezv,théatei.animprovedinvitromodelofhumanintestinalfollicle-associatedepitheliumtostudynanoparticletransportbymcells[j].eurjpharmsci,2007,30:380-391.
[4]  desaimp,labhasetwarv,amidongl,etal.gastrointestinaluptakeofbiodegradablemicroparticles:effectofparticlesize[j].pharmres,1996,13:1838-1845.
[5]  laisk,hidak,manst,etal.privilegeddeliveryofpolymernanoparticlestotheperinuclearregionoflivecellsviaanon-clathrin,non-degradativepathway[j].biomaterials,2007,28:2876-2884.
[6]  behrensi,penaai,alonsomj,etal.comparativeuptakestudiesofbioadhesiveandnon-bioadhesivenanoparticlesinhumanintestinalcelllinesandrats:theeffectofmucusonparticleadsorptionandtransport[j].pharmres,2002,19:1185-1193.
[7]  ishidat,harashimah,kiwadah.liposomeclearance[j].bioscirep,2002,22:197-224.
[8]  poelstrak,prakashj,beljaarsl.drugtargetingtothediseasedliver[j].jcontrolrelease,2012,161:188-197.
[9]  manzano-alonsoml,castellano-tortajadag.reactivationofhepatitisbvirusinfectionaftercytotoxicchemotherapyorimmunosuppressivetherapy[j].worldjgastroenterol,2011,17:1531-1537.
[10]  houxp,wangl,wangxt,etal.studyonthehepatocyticcelltargetabilityofliposomes[j].actapharmsin(药学学报),2003,38:143-146.
[11]  schroedera,levinscg,cortezc,etal.lipid-basednanotherapeuticsforsirnadelivery[j].jinternmed,2010,267:9-21.
[12]  roerdinkf,dijkstraj,hartmang,etal.theinvolvementofparenchymal,kupfferandendotheliallivercellsinthehepaticuptakeofintravenouslyinjectedliposomes.effectsoflanthanumandgadoliniumsalts[j].biochimbiophysacta,1981,677:79-89.
[13]  chenwg,liuyg,wangsb,etal.researchprogressinco-deliveryofgeneandchemotherapydrugswithcationicliposomecarrierforcancertherapy[j].actapharmsin(药学学报),2012,47:986-992.
[14]  willekensfl,werrejm,kruijtjk,etal.liverkupffercellsrapidlyremoveredbloodcell-derivedvesiclesfromthecirculationbyscavengerreceptors[j].blood,2005,105:2141-2145.
[15]  melgertbn,weertb,schellekensh,etal.thepharma-cokineticandbiologicalactivityprofileofdexamethasonetargetedtosinusoidalendothelialandkupffercells[j].jdrugtarget,2003,11:1-10.
[16]  simbergd,weismans,talmony,etal.theroleoforganvascularizationandlipoplex-seruminitialcontactinintravenousmurinelipofection[j].jbiolchem,2003,278:39858-39865.
[17]  abrahamam,waluboa.theeffectofsurfacechargeonthedispositionofliposome-encapsulatedgentamicintotheratliver,brain,lungsandkidneysafterintraperitonealadministration[j].intjantimicrobagents,2005,25:392-397.
[18]  steichensd,caldorera-moorem,peppasna.areviewofcurrentnanoparticleandtargetingmoietiesforthedeliveryofcancertherapeutics[j].eurjpharmsci,2012,48:416-427.
[19]  davisme,chenzg,shindm.nanoparticletherapeutics:anemergingtreatmentmodalityforcancer[j].natrevdrugdiscov,2008,7:771-782.
[20]  duncanr.thedawningeraofpolymertherapeutics[j].natrevdrugdiscov,2003,2:347-360.
[21]  drehermr,liuw,michelich,cr,etal.tumorvascularpermeability,accumulation,andpenetrationofmacromoleculardrugcarriers[j].jnatlcancerinst,2006,98:335-344.
[22]  alexisf,pridgene,molnarlk,etal.factorsaffectingtheclearanceandbiodistributionofpolymericnanoparticles[j].molpharm,2008,5:505-515.
[23]  lilaas,matsumotoh,doiy,etal.tumor-type-dependentvascularpermeabilityconstitutesapotentialimpedimenttothetherapeuticefficacyofliposomaloxaliplatin[j].eurjpharmbiopharm,2012,81:524-531.
[24]  takarak,hatakeyamah,kibriag,etal.size-controlled,dual-ligandmodifiedliposomesthattargetthetumorvasculatureshowpromiseforuseindrug-resistantcancertherapy[j].jcontrolrelease,2012,162:225-232.
[25]  nagayasua,uchiyamak,kiwadah.thesizeofliposomes:afactorwhichaffectstheirtargetingefficiencytotumorsandtherapeuticactivityofliposomalantitumordrugs[j].advdrugdelivrev,1999,40:75-87.
[26]  yany,qixr.preparationandpropertiesoffolatereceptor-targetedcationicliposomes[j].actapharmsin(药学学报),2008,43:1134-1139.
[27]  joshimd,ungerwj,stormg,etal.targetingtumorantigenstodendriticcellsusingparticulatecarriers[j].jcontrolrelease,2012,161:25-37.
[28]  ibsens,benchimolbm,eseners.fluorescentmicroscopesystemtomonitorreal-timeinteractionsbetweenfocusedultrasound,echogenicdrugdeliveryvehicles,andlivecellmembranes[j].ultrasonics,2013,53:178-184.
[29]  hillaireauh,couvreurp.nanocarriers'entryintothecell:relevancetodrugdelivery[j].cellmollifesci,2009,66:2873-2896.
[30]  ahsanf,rivasip,khanma,etal.targetingtomacrophages:roleofphysicochemicalpropertiesofparticulatecarriers-liposomesandmicrospheres-onthephagocytosisbymacrophages[j].jcontrolrelease,2002,79:29-40.
[31]  grovese,dartae,covarelliv,etal.molecularmechanismsofphagocyticuptakeinmammaliancells[j].cellmollifesci,2008,65:1957-1976.
[32]  championja,mitragotris.roleoftargetgeometryinphagocytosis[j].procnatlacadsciusa,2006,103:4930-4934.
[33]  moghimism,szebenij.stealthliposomesandlongcirculatingnanoparticles:criticalissuesinpharmacokinetics,opsonizationandprotein-bindingproperties[j].proglipidres,2003,42:463-478.
[34]  vonarbourga,passiranic,saulnierp,etal.parametersinfluencingthestealthinessofcolloidaldrugdeliverysystems[j].biomaterials,2006,27:4356-4373.
[35]  harashimah,sakatak,funatok,etal.enhancedhepaticuptakeofliposomesthroughcomplementactivationdependingonthesizeofliposomes[j].pharmres,1994,11:402-406.
[36]  vonarbourga,passiranic,saulnierp,etal.evaluationofpegylatedlipidnanocapsulesversuscomplementsystemactivationandmacrophageuptake[j].jbiomedmaterresa,2006,78:620-628.
[37]  harashimah,huongtm,ishidat,etal.synergisticeffectbetweensizeandcholesterolcontentintheenhancedhepaticuptakeclearanceofliposomesthroughcomplementactivationinrats[j].pharmres,1996,13:1704-1709.
[38]  rigottia,actonsl,kriegerm.theclassbscavengerreceptorssr-biandcd36arereceptorsforanionicphosphor-lipids[j].jbiolchem,1995,270:16221-16224.
[39]  chonna,cullispr,devinedv.theroleofsurfacechargeintheactivationoftheclassicalandalternativepathwaysofcomplementbyliposomes[j].jimmunol,1991,146:4234-4241.
[40]  devinedv,wongk,serranok,etal.liposome-complementinteractionsinratserum:implicationsforliposomesurvivalstudies[j].biochimbiophysacta,1994,1191:43-51.
[41]  zhoudm,xiexf,zhuangy,etal.theroleofsurfacechargeinmonocyteactivationandcellviabilityinducedbycationicliposomes[j].actabiophysin(生物物理学报),2010,26:726-734.
[42]  sunhc,xuxw,zhangk,etal.advanceresearchonpathwaysandmechanismsofnanoparticletransmembranetransport[j].jjilinuniv(meded)(吉林大学学报医学版),2011,37:1157-1160.
[43]  tangl,fantm,borstlb,etal.synthesisandbiologicalresponseofsize-specific,monodispersedrug-silicananoconjugates[j].acsnano,2012,6:3954-3966.
[44]  tangl,gabrielsonnp,uckunfm,etal.size-dependenttumorpenetrationandinvivoefficacyofmonodispersedrug-silicananoconjugates[j].molpharm,2013,10:883-892.
[45]  rejmanj,oberlev,zuhornis,etal.size-dependentinternalizationofparticlesviathepathwaysofclathrin-andcaveolae-mediatedendocytosis[j].biochemj,2004,377:159-169.
[46]  chent,wangrt,wanz,etal.constructionandevaluationofnon-specifictargetingcationicpolymerlipidliposomes[j].actapharmsin(药学学报),2010,45:359-364.
[47]  maos,germershauso,fischerd,etal.uptakeandtransportofpeg-graft-trimethyl-chitosancopolymer-insulinnanocomplexesbyepithelialcells[j].pharmres,2005,22:2058-2068.
[48]  yamashitaf,hashidam.pharmacokineticconsiderationsfortargeteddrugdelivery[j].advdrugdelivrev,2013,65:139-147.
[49]  zhouw,pingqn,wanglj.influenceofparticlesizeonthetissuedistributionofhydroxycamptothecinliposomes[j].jchinapharmuniv(中国药科大学学报),2005,36:125-128.
[50]  moghimism,patelhm.modulationofmurinelivermacrophageclearanceofliposomesbydiethylstilbestrol.theeffectofvesiclesurfacechargeandaroleforthecomplementreceptormac-1(cd11b/cd18)ofnewlyrecruitedmacrophagesinliposomerecognition[j].jcontrolrelease,2002,78:55-65.
[51]  chonna,semplesc,cullispr.associationofbloodproteinswithlargeunilamellarliposomesinvivo.relationtocirculationlifetimes[j].jbiolchem,1992,267:18759-18765.
[52]  leejs,ankonem,pieterse,etal.circulationkineticsandbiodistributionofdual-labeledpolymersomeswithmodulatedsurfacechargeintumor-bearingmice:comparisonwithstealthliposomes[j].jcontrolrelease,2011,155:282-288.
[53]  higuchiy,nishikawam,kawakamis,etal.uptakecharacteristicsofmannosylatedandfucosylatedbovineserumalbumininprimaryculturedratsinusoidalendothelialcellsandkupffercells[j].intjpharm,2004,287:147-154.
[54]  liechtywb,peppasna.expertopinion:responsivepolymernanoparticlesincancertherapy[j].eurjpharmbiopharm,2012,80:241-246.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133